DNTH
Dianthus Therapeutics Inc.
$34.98
+$1.24(+3.68%)
51
Overall
60
Value
60
Tech
34
Quality
Market Cap
$1.06B
Volume
322.82K
52W Range
$13.37 - $40.16
Target Price
$63.45
Order:
Income Statement
| Metric | Trend | Chart | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Total Revenue | -- | -- | -- | -- | $6.4M | $2.8M | $6.2M | ||
| Total Revenue | -- | -- | -- | -- | $6.4M | $2.8M | $6.2M | ||
| GROSS PROFIT | |||||||||
| Gross Profit | -- | -- | -- | -- | -- | $2.8M | $6.2M | ||
| OPERATING EXPENSES | |||||||||
| Operating Expenses | $-60.0M | $83.0M | $78.7M | $74.7M | $36.1M | $51.0M | $108.1M | ||
| Research & Development | $41.3M | $59.2M | $50.6M | $46.8M | $29.4M | $32.8M | $83.1M | ||
| Research Expense | $41.3M | $59.2M | $50.6M | $46.8M | $29.4M | $32.8M | $83.1M | ||
| Selling, General & Administrative | $18.6M | $23.8M | $28.1M | $27.9M | $6.7M | $18.2M | $25.0M | ||
| General & Administrative Expenses | $18.6M | $23.8M | $28.1M | $27.9M | $6.7M | $18.2M | $25.0M | ||
| Salaries & Wages | $-10.7M | $-10.0M | -- | -- | -- | $2.9M | $12.9M | ||
| Depreciation & Amortization | $-875.0K | $-1.8M | $2.0M | $2.0M | $30.0K | $67.0K | $96.0K | ||
| Depreciation & Amortization | $-875.0K | $-1.8M | $2.0M | $2.0M | $30.0K | $67.0K | $96.0K | ||
| Other Operating Expenses | -- | -- | -- | -- | $236.0K | $394.0K | $454.0K | ||
| OPERATING INCOME | |||||||||
| Operating income | $-60.0M | $-83.0M | $-78.7M | $-74.7M | $-29.7M | $-48.2M | $-101.9M | ||
| EBITDA | $-56.6M | $-74.9M | $-73.0M | $-13.1M | $-29.6M | $-47.8M | $-84.6M | ||
| NON-OPERATING ITEMS | |||||||||
| Interest Income Operating | -- | -- | -- | -- | -- | $4.8M | $17.4M | ||
| Intinc | $2.4M | $6.2M | $3.8M | $3.6M | $1.1M | $4.8M | $17.4M | ||
| Net Non-Operating Interest Income/Expense | $2.4M | $6.2M | $3.8M | $3.6M | $-1.1M | $4.8M | $17.4M | ||
| Other Income/Expense | -- | -- | $-51.2M | $-45.1M | $84.0K | $60.0K | $554.0K | ||
| Other Special Charges | -- | -- | $51.2M | $45.1M | $-52.0K | $-60.0K | $-554.0K | ||
| PRE-TAX INCOME | |||||||||
| EBIT | $-57.5M | $-76.8M | $-74.9M | $-13.1M | $-29.7M | $-48.2M | $-85.0M | ||
| Pre-Tax Income | $-57.5M | $-76.8M | $-74.9M | $-71.1M | $-28.5M | $-43.6M | $-85.0M | ||
| NET INCOME | |||||||||
| Net Income | $-57.5M | $-76.8M | $-74.9M | $-13.1M | $-28.5M | $-43.6M | $-85.0M | ||
| Net Income (Continuing Operations) | $-57.5M | $-76.8M | $-74.9M | $-71.1M | $-28.5M | $-43.6M | $-85.0M | ||
| Net Income (Discontinued Operations) | $-57.5M | $-76.8M | $-74.9M | $-13.1M | $-28.5M | $-43.6M | $-85.0M | ||
| Net Income (Common Stockholders) | $-57.6M | $-76.8M | $-74.9M | $-13.1M | $-28.5M | $-43.6M | $-85.0M | ||
| Normalized Income | -- | -- | -- | $-56.2M | -- | -- | $-84.3M | ||
| TOTALS | |||||||||
| Total Expenses | $-60.0M | $83.0M | $78.7M | $74.7M | $36.1M | $51.0M | $108.1M | ||
| SHARE & EPS DATA | |||||||||
| Average Shares Outstanding | $1.1M | $2.3M | $2.7M | $3.4M | $3.7M | $5.2M | $33.3M | ||
| Average Shares Outstanding (Diluted) | $1.1M | $2.3M | $2.7M | $3.4M | $3.7M | $5.2M | $33.3M | ||
| Shares Outstanding | $2.1M | $2.5M | $3.0M | $3.7M | $3.8M | $29.3M | $32.1M | ||
| Basic EPS | -- | -- | $-27.36 | $-20.64 | $-20.64 | $-8.45 | $-2.55 | ||
| Basic EPS (Continuing Operations) | -- | -- | $-27.36 | $-20.64 | $-20.64 | $-8.45 | $-2.55 | ||
| Diluted EPS | $-50.08 | $-33.12 | $-27.36 | $-20.64 | $-20.64 | $-8.45 | $-2.55 | ||
| Diluted EPS (Continuing Operations) | -- | $-33.12 | -- | $-20.64 | $-20.64 | $-8.45 | $-2.55 | ||
| OTHER METRICS | |||||||||
| Accretion On Preferred Stock | $88.0K | -- | -- | -- | -- | -- | -- | ||
| Other Gand A | $18.6M | $23.8M | $28.1M | $27.9M | $6.7M | $18.2M | $25.0M | ||
| Otherunder Preferred Stock Dividend | $88.0K | -- | -- | -- | -- | -- | -- | ||
| Preferred Stock Dividends | $88.0K | -- | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $18.6M | $-6.1M | $6.2M | $6.2M | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DNTH | $34.98 | +3.7% | 322.82K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Dianthus Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW